News

News, 12 Jun 2022

JIA Awareness Week 2022

NRAS and JIA-at-NRAS are pleased to announce our first ever JIA Awareness Week (JIA AW) is taking place on 13th to 17th June 2022. The aim of the campaign is to raise awareness of JIA and eliminate the misconceptions held by many about what JIA is. During JIA Awareness Week we hope to educate and […]

News, 01 Jun 2022

Global RA Network launches Rheumatoid Arthritis Dashboard

The new advocacy tool identifies gaps in the delivery of RA care and treatment in around the world. Copenhagen, June 1, 2022 – The Global RA Network (the “Network”) today launched a new powerful advocacy tool – the RA Dashboard – as part of its initiatives to improve models of care for people with rheumatoid […]

News, 27 May 2022

Are there risks for immunosuppressed and Monkeypox?

It is an evolving situation but at the moment doesn’t seem to be anything to worry about. The number of cases are likely to be under 10,000. We will be monitoring the advice from the UKHSA. There doesn’t appear to be a greater risk at the moment to those who are immunosuppressed. Anyone who does […]

News, 26 May 2022

NRAS launch new module for their major new e-learning programme SMILE-RA

Join the nearly 1,000 people who are SMILING! Last September, NRAS launched their unique and engaging e-learning experience for people with RA and their families who want to understand more about RA, its treatments and how to minimise its impact on your quality of life. SMILE-RA has a modular approach to learning, so each module is […]

News, 21 Apr 2022

Covid-19 Outcomes in Children With JIA

Severe COVID-19 Outcomes Rare Among Children and Young People With Rheumatic Diseases. According to a press release issued by the Children Arthritis and Rheumatology Research Alliance (CARRA), severe Covid-19 outcomes and hospitalisations are uncommon among children with JIA and other musculoskeletal diseases. The research used data from the following to identify children with Rheumatic and […]

News, 13 Apr 2022

Thousands More Patients to Access Second Ground-Breaking Antiviral

Thousands more vulnerable people eligible to receive the UK’s second antiviral Paxlovid, which has been added to the PANORAMIC national study. Paxlovid reduced the risk of hospitalisation or death by 88% in clinical trials and is already available directly through the NHS to highest-risk patients. The UK has procured more antivirals per head than any […]

News, 13 Apr 2022

The Spring Booster

The spring booster vaccine is now being offered to those that are aged over 75 and those aged over 12 who are immunosuppressed. For many people that are immune suppressed this will be their 5th dose. As long as there is a 3-month gap between the date of their last vaccination, patients can now access […]

News, 21 Mar 2022

NHS Launch platform to Empower Patients

The NHS have now released a Platform in which patients can access information the latest average wait time to see a specialist in their area as well as general information and support. The site will be updated weekly and is ‘open-access’. This means that it is available to friends, family and relatives as well. The […]

News, 08 Feb 2022

NRAS, partners with Inmedix to develop ‘Stress Matters’ resources

The National Rheumatoid Arthritis Society (NRAS) proudly announces that thanks to funding provided by Inmedix, the charity is embarking on a project to develop resources explaining the impact of stress on developing or exacerbating rheumatoid arthritis symptoms. The project will include a UK nationwide survey of those living with rheumatoid arthritis (RA) leading to the […]

News, 06 Dec 2021

News from NICE on anti-fibrotic treatment for non-IPF patients

NRAS and NICE are pleased to announce that our recent campaign, backed by patients, families and medical experts, to end the inhumane restrictions on a life-extending anti-fibrotic drug for patients with pulmonary fibrosis has been successful. As of 18 October 2021, NICE has agreed that UK doctors will soon be able to prescribe the anti-fibrotic […]

How can we help?